Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response

The molecular dynamics of pancreatic ductal adenocarcinoma (PDAC) under chemotherapy remain incompletely understood. The widespread use of neoadjuvant chemotherapy (NAC) provides a unique opportunity to investigate PDAC samples post-chemotherapy. Leveraging a cohort from Fudan University Shanghai Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Rong, Xu, Jin, Wang, Wei, Meng, Qingcai, Shao, Chenghao, Zhang, Yiyin, Lei, Yubin, Zhang, Zifeng, Liu, Yuan, Du, Qiong, Sun, Xiangjie, Wu, Di, Liang, Chen, Hua, Jie, Zhang, Bo, Yu, Xianjun, Shi, Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591062/
https://www.ncbi.nlm.nih.gov/pubmed/37852179
http://dx.doi.org/10.1016/j.xcrm.2023.101234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591062/
https://www.ncbi.nlm.nih.gov/pubmed/37852179
http://dx.doi.org/10.1016/j.xcrm.2023.101234

Ejemplares similares